Trips: How Hallucinogens Work in Your Brain
Trips shows, using color illustrations, the latest research, and bleeding-edge cultural analogies, how the still-mysterious hallucinogens may work in the still-mysterious brain. Written in language a general audience can understand, the book's tone is light and irreverent, yet at the same time deals with the drug culture in a serious way.
Trips offers readers a rare look at the social, cultural, historical, and scientific phenomenon of psychedelics-through the eyes of artists who've grown up with them, regulators who control them, federal scientists who approve and fund their research, and scientists who've spent careers studying them—and in the process fills a growing need for truthful information about drugs. For a generation, people have been worried about false horrors attributed to LSD-chromosome damage (LSD doesn't; coffee and aspirin do), suicide, madness, and flashbacks (no such thing). There are, however, real problems associated with hallucinogens, which until now have been unknown, ignored, or untranslated from the scientific literature. Trips separates the facts from the falsehoods and provides, through the combination of Pellerin's text and the artwork of legendary American artist Robert Crumb, a practical, entertaining, and yet rock-solid guide.
What people are saying - Write a review
We haven't found any reviews in the usual places.
EVERYBODY WANT TO GO TO HEAVEN NOBODY WANT TO DIE
JUST THINK OF IT AS EVOLUTION IN ACTION
PIONEERS ARE THE ONES WITH ARROWS IN THEIR BACKS
AS CLOSE AS YOU GET TO PSYCHOSIS WITHOUT BEING PSYCHO YOURSELF
THE 1960s LSDOUT OF KILTER WITH THE BASIC ASSUMPTIONS OF WESTERN MEDICINE
19701990 ANIMAL PHARMROUGH ON RATS
19911993 CIVILIZATION HO
LSD HERE NOW
5-HT2A receptor activity addiction agonist AH AH Albert Hofmann alcohol Alexander Shulgin alkaloids amphetamine animals antidepressants approved axon ayahuasca bad trips behavior brain called cells Center chemical chemist chemistry cinogens classic hallucinogens clinical compounds develop dopamine dose Drug Abuse drug discrimination effects experience federal feel funding hallu hallucino hallucinogen research hallucinogens Heffter Research Institute hippie human ibogaine images Institute on Drug interview investigators ketamine Lee and Shlain levels marijuana MDMA medicine Mental Health mescaline National Institute neurons neuroscience neurotoxic neurotransmitters NIDA norepinephrine patients peyote Ph.D pharmacology Phenethylamines potential problems Prozac psilocin psilocybin psychiatric psychiatrists Psychoactive Drugs psychological psychotherapy response Rick Strassman Schedule scientists Shulgin Slightly Moderately Stephen Szara substance abuse therapeutic therapy there's things tion treatment University users visual volunteers ZAP Comix